Alain Bonafe
Alain Bonafe

Clinical Career

  • Since 2016: University Professor - Hospital practitioner, Hôpital Gui de Chauliac, CHRU Montpellier
  • 1997-2015: Professor of Neuroradiology, Head of the Neuroradiology department, Hôpital Gui de Chauliac, CHRU Montpellier
  • 1988-1997: Hospital practitioner and Professor of university, CHU Toulouse
  • 1984-1987: Hospital practitioner, CHU Toulouse
  • 1979-1983: Senior Registrar at the University, CHU Toulouse
  • 1979: Medical Doctor Diploma, CHU Toulouse

Education Responsabilities and Meeting Organisation

President of the French Society of Neuroradiology (SFNR)

Active Areas of Research

Interventional Neuroradiology: Endovascular treatment of aneurysms, brain AVMs, ischemic stroke

Principal Investigator of several clinicals studies including:

  • SENAT: Etude non interventionnelle nationale prospective de morbi-mortalité et d'efficacité du traitement endovasculaire sélectif des anévrysmes intracraniens à l'aide du stent Neuroform
  • MAPS: A prospective, randomized, multicenter trials investigating Matrix coils and GDC coils for the treatment of intracranial saccular aneurysms
    Interventional - ClinicalTrials.gov identifier: NCT00396981
  • GREAT: Essai contrôlé randomisé HydroCoils® 2ème génération versus coils platine dans le traitement endovasculaire des anévrismes intracrâniens (French coordinator)
  • CONSCIOUS 3: A prospective, multi-center, double-blind, randomized, placebocontrolled, parallel-group study to assess the efficacy and safety of clazosentan in reducing vasospasm-related morbidity and all cause mortality in adult patients with aneurysmal subarachnoid hemorrhage treated by endovascular coiling.
    Interventional - ClinicalTrials.gov identifier: NCT00940095
  • SWIFT: SOLITAIRE™ FR With the Intention For Thrombectomy (SWIFT) Study.
    Interventional - ClinicalTrials.gov identifier: NCT01054560
  • STAR: Solitaire FR Thrombectomy for Acute Revascularisation (STAR).
    ClinicalTrials.gov identifier:NCT01327989
  • Etude DIVERSION: Evaluation du traitement par Système de Diversion de flux (ou flow diverter) intra-vasculaire des anévrismes intrâcraniens